The childhood asthma management program (CAMP): Design, rationale, and methods

  • Childhood Asthma Management Program Research Group
  • , Gail G. Shapiro
  • , Thomas R. DuHamel
  • , Timothy G. Wighton
  • , Tamara Chinn
  • , C. Warren Bierman
  • , Clifton T. Furukawa
  • , Leonard C. Altman
  • , Frank S. Virant
  • , Paul V. Williams
  • , Dominick A. Minotti
  • , Michael S. Kennedy
  • , Jonathan W. Becker
  • , Chris Reagan
  • , Heather Eliassen
  • , Dan Crawford
  • , Babi Hammond
  • , Grace Strodtbeck
  • , Marian Sharpe
  • , Scott Weiss
  • Dirk Greineder, Walter Torda, Martha Tata, Peter Barrant, Anthony DeFilippo, Mary Grace, Stephanie Haynes, Margaret Higham, Susan Kelleher, Jay Koslof, Nancy Madden, Dana Mandel, Agnes Martinez, Jean McAuliffe, Paola Pacella, Paula Parks, Anne Plunkett, Kay Seligsohn, June Traylor, Melissa Van Horn, Janice Ware, Carolyn Wells, Ann Whitman, Joe Reisman, Ian MacLusky, Henry Levison, Anita Hall, Yola Benedet, Jennifer Chay, Michelle Collinson, Jane Finlayson-Kulchin, Kenneth Gore, Melody Miki, Renée Sananes, N. Franklin Adkinson, Peyton Eggleston, Karen Huss, Leslie Plotnick, Margaret Pulsifer, Cynthia Rand, Barbara Wheeler, Nancy Bollers, Kimberly Hyatt, Betsy Leritz, Mildred Pessaro, Stephanie Philips, Stanley Szefler, Harold S. Nelson, D. Sundström, Bruce Bender, Kristin Brelsford, Melanie Gleason, Joseph Hassell, Caroline Hendrickson, Charles G. Irvin, Tara Junk, Andrew Liu, Joseph Spahn, Michael P. White, Jeryl Feeley, Jessyca Bridges, Jody Ciacco, Michael Eltz, Michael Flynn, Marcia Hefner, Daniel Hettleman, Jeffrey Jacobs, Alan Kamada, Sai Nimmagadda, Kendra Sandoval, Jessica Sheridan, Trella Washington, Eric Willcutt, Robert Zeiger, Anthony Horner, Noah Friedman, Al Jalowayski, Alan Lincoln, Michael H. Mellon, Michael Schatz, Kathleen Harden, Linda L. Galbreath, Ellen Hanson, Elaine M. Jenson, Shirley King, Brian Lopez, Michaela Magiari, Catherine A. Nelle, Senia Pizzo, Eva Rodriquez, James G. Easton, Kathleen Mostafa, Avraham Moscona, Karen Sandoval, Bennie McWilliams, Robert Annett, H. William Kelly, Mary Spicher, Diane Becker, Selda Bereket, Marisa Braun, Shannon Bush, David Hunt, Margaret Moreshead, Barbara Ortega, Robert C. Strunk, Gordon R. Bloomberg, James M. Corry, Thomas F. Smith, Ellen Albers, Bernadette Davantes, Gregg Belle, Marisa Dolinsky, Edwin B. Fisher, Stephen J. Gaioni, Emily Glynn, Cathy Herman, Debra Kemp, Claire Lawhon, Sharon Meltzer, Cynthia Moseid, Tina Oliver-Welker, Denise Rodgers, Carl Turner, Deborah K. White, Mary Caesar, Diana S. Richardson, Elizabeth Ryan, Susan C. Sylvia, Reuben Cherniack, James Tonascia, Curtis Meinert, Debra Amend-Libercci, Patricia Belt, Karen Collins, Betty Collison, Christopher Dawson, John Dodge, Michele Donithan, Dawn Easton, Vera Edmonds, Cathleen Ewing, Judith Harle, Robert Huffman, Kung Yee Liang, Jill Meinert, Deborah Nowakowski, Rosetta Owens, Michael Smith, Alice Sternberg, Mark Van Natta, Robert Wise, Robert Rice, Bob Hughes, Tom Lynch, Sarma Vadlamani, Robert G. Hamilton, Carol Schatz, Jack Wisenauer, Ronald J. Harbeck, Rhonda Emerick, Brian Watson, Cindi Culkin, Sarah Oliver, Colleen Lum Lung, Ann Mullen, Virginia Taggart, Pamela Randall, Paul Albert, Suzanne Hurd, James Kiley, Margaret Wu, Sydney Parker, William Letvenko, William Repko, Rolland Poust, David Herold, Dennis Elbert, Howard Eigen, Michelle Cloutier, John Connett

Research output: Contribution to journalArticlepeer-review

329 Scopus citations

Abstract

The Childhood Asthma Management Program (CAMP) is a multicenter, randomized, double-masked clinical trial designed to determine the long-term effects of three inhaled treatments for mild to moderate childhood asthma: budesonide (a glucocorticoid used daily) and albuterol (a short-acting β-agonist bronchodilator used as needed); nedocromil (a nonsteroid anti-inflammatory agent used daily) and albuterol; and placebo and albuterol. One thousand forty-one children (32% from ethnic minority groups), aged 5 to 12 years at screening, are currently participating. The primary outcome measure is lung growth as indicated by postbronchodilator forced expiratory volume in 1 second (FEV1) percent of predicted, observed over 5- to 6-year period. The trial also assesses differences between treatment groups with respect to airway responsiveness, morbidity, physical growth and development, and psychological growth and development. This report describes the design of the trial, the rationale for the design choices made, and the methods used to carry out the trial.

Original languageEnglish
Pages (from-to)91-120
Number of pages30
JournalControlled clinical trials
Volume20
Issue number1
DOIs
StatePublished - Feb 1999

Keywords

  • Albuterol
  • Allergens
  • Anti-inflammatory agents
  • Atopy
  • Bronchial provocation test
  • Bronchodilator agents
  • Budesonide
  • Childhood asthma
  • Clinical trials
  • Environmental exposure
  • Glucocorticoids
  • Growth
  • Inhaled bronchodilator
  • Nedocromil
  • Psychological test
  • Spirometry

Fingerprint

Dive into the research topics of 'The childhood asthma management program (CAMP): Design, rationale, and methods'. Together they form a unique fingerprint.

Cite this